Research Highlight

Princess Margaret Cancer Consortium leadership and members share updates with the Network

On Thursday, March 20, 2025, leadership and researchers from the Princess Margaret Cancer Consortium (PM2C) presented their work to Network members as part of the MOHCCN seminar series. 

This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. 

This event was co-chaired by James Pereira, a member of the MOHCCN Patient Working Group, and by Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.

Watch the full video

 

Speakers

Consortium Activities Update

  • Lillian Siu, MD, FRCPC - Medical oncologist, Princess Margaret Cancer Centre, University Health Network; MOHCCN consortium lead

Research Presentations

  • Bringing whole genome transcriptome sequencing (WGTS) to patient care and clinicians: the prospective MOHCCN-O study and Molecular Tumor Board at PM2C.
  • Evaluating shallow Whole Genome Sequencing (sWGS) Prior to deep-WGS Assays to Estimate Tumor Purity in Oncology 
    • Carlos Diego Holanda Lopes, MD - Clinical research fellow, supervised by Jeffrey Bruce, PhD and Philippe Bedard, MD, Princess Margaret Cancer Centre, University Health Network
    • View scientific and plain language abstracts

Related Team Member

  • Sherri
    Christian

    Consortium LeaderMOHCCN Steering CommitteeWorking Group Member
  • Regional Consortia

    Atlantic Cancer Consortium

    • Prince Edward Island
    • New Brunswick
    • Newfoundland and Labrador
    • Nova Scotia
    We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...
    Read more
    Digital illustration of DNA in dark blue and pink